1. Home
  2. TOPP vs GBIO Comparison

TOPP vs GBIO Comparison

Compare TOPP & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • GBIO
  • Stock Information
  • Founded
  • TOPP 2014
  • GBIO 2016
  • Country
  • TOPP United States
  • GBIO United States
  • Employees
  • TOPP N/A
  • GBIO N/A
  • Industry
  • TOPP
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOPP
  • GBIO Health Care
  • Exchange
  • TOPP NYSE
  • GBIO Nasdaq
  • Market Cap
  • TOPP 26.6M
  • GBIO 29.2M
  • IPO Year
  • TOPP 2025
  • GBIO 2020
  • Fundamental
  • Price
  • TOPP $1.70
  • GBIO $0.36
  • Analyst Decision
  • TOPP
  • GBIO Strong Buy
  • Analyst Count
  • TOPP 0
  • GBIO 4
  • Target Price
  • TOPP N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • TOPP 11.8K
  • GBIO 598.9K
  • Earning Date
  • TOPP 08-11-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • TOPP N/A
  • GBIO N/A
  • EPS Growth
  • TOPP N/A
  • GBIO N/A
  • EPS
  • TOPP N/A
  • GBIO N/A
  • Revenue
  • TOPP $16,117,227.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • TOPP N/A
  • GBIO N/A
  • Revenue Next Year
  • TOPP N/A
  • GBIO N/A
  • P/E Ratio
  • TOPP N/A
  • GBIO N/A
  • Revenue Growth
  • TOPP 0.44
  • GBIO 146.47
  • 52 Week Low
  • TOPP $0.97
  • GBIO $0.32
  • 52 Week High
  • TOPP $4.50
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • GBIO 43.92
  • Support Level
  • TOPP N/A
  • GBIO $0.35
  • Resistance Level
  • TOPP N/A
  • GBIO $0.38
  • Average True Range (ATR)
  • TOPP 0.00
  • GBIO 0.03
  • MACD
  • TOPP 0.00
  • GBIO -0.00
  • Stochastic Oscillator
  • TOPP 0.00
  • GBIO 3.33

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: